[Target therapy and governance: the breast cancer PDTA of the Venetian Oncology Network.]

Abstract

Mutational oncology is becoming a fundamental element of diagnostic-therapeutic care pathways and requires new organizational models that allow for the aggregation of administrative, clinical and biomolecular data. From the experience of the Periplo Foundation in measuring the diagnostic and therapeutic care pathways (DTCP) indicators of almost 20 thousand women with breast cancer in five Italian regions, which showed the difficulty of measuring the efficiency of diagnostic-therapeutic care pathways based on the data available in the existing databases, the Foundation hopes for the creation of digital environments built with the aim of showing the greater/lesser efficiency of the health system.

• Authors: Pierfranco Conte
• Journal: Recenti progressi in medicina (Recenti Prog Med) Vol. 112 Issue 12 Pg. 816-820 (12 2021) ISSN: 2038-1840 [Electronic] Italy
• Vernacular Title: Target therapy e governance: il PDTA del tumore della mammella della Rete Oncologica Veneta.
• PMID: 34924579 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• propanoldiaminetetracetic acid
• Edetic Acid

Topics

• Breast Neoplasms (therapy)
• Critical Pathways
• Edetic Acid (analogs & derivatives)
• Female
• Humans
• Male
• Medical Oncology